No Data
Cassava Sciences Halts Alzheimer's Drug Trials After Phase 3 Results
Cassava Sciences Cut to Neutral From Buy by HC Wainwright & Co.
Cassava Sciences Price Target Announced at $116.00/Share by HC Wainwright & Co.
Cassava Sciences Analyst Ratings
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Tuesday; Cassava Sciences to Advance, MicroStrategy to Decline
H.C. Wainwright Downgrades Cassava Sciences(SAVA.US) to Hold Rating
玄学炒股的美股韭菜 : They will definitely do this.
Johnny Mnemonic : it's sitting on a support right now, but these shorts love to push a knife into you